Premier Alternatives

Elysium Health

New York, NY · Founded 2014 · Privately Held (backing)

Producer of health supplements intended to turn critical scientific advancements into accessible consumer products. Elysium Health is based in New York, NY and was founded in 2014. Its last known valuation is $240 million. It has raised $392 million across 1 recorded round; the latest was a $20 million early-stage round in Oct 2016.

Last price · $/share
—
Implied valuation
$240.0M
Total raised
$391.6M
Last round
Early Stage VC
Oct 2016

Elysium Health key facts

  • Producer of health supplements intended to turn critical scientific advancements into accessible consumer products.
  • Elysium Health’s last known valuation is $240.0M.
  • It has raised $391.6M across 1 recorded rounds; the latest was Early Stage VC ($20.0M) in Oct 2016.
  • Notable investors include General Catalyst, Gaingels, Calm Ventures, Western Technology Investment, Sprint VC — 28 tracked in total.
  • Elysium Health has filed 1 Form D with the SEC, most recently Dec 2016 ($20.0M sold to 6 investors).
  • Status: Privately Held (backing).
Free account
More of Elysium Health with a free account
  • ·The complete investor list: 28 names
  • ·Watch Elysium Health: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Elysium Health funding rounds

1 rounds
Oct 2016Early Stage VC$20.0MSEC filing▮
Full funding history →

Elysium Health valuation

Elysium Health's last known valuation is $240 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How much has Elysium Health raised?

Elysium Health has raised $392 million in total; 1 of its rounds is on record. The largest on record was a $20 million early-stage round in Oct 2016.

Elysium Health has filed 1 Form D with the SEC, most recently in Dec 2016 ($20 million sold to 6 investors).

Elysium Health investors

28 investors are on record for Elysium Health, including General Catalyst, Gaingels, Calm Ventures and Western Technology Investment. By type, the record holds 11 venture capital firms, 1 family office and 1 growth equity firm. The early-stage round in Oct 2016 drew 6 investors.

About Elysium Health

Producer of health supplements intended to turn critical scientific advancements into accessible consumer products. The company's supplements include a health product that is clinically validated to enhance and sustain NAD+ levels in humans, which decline with age, as well as provides an at-home test that helps people discover their biological age, enabling consumers to enhance their bodily cellular metabolism and maintain an enhanced immune system.

Sector
Healthcare
HQ
New York, NY, United States
Founded
2014
Employees
59
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$240.0M

Elysium Health’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.